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CaZ+/Cll increases the L-[3H]glutamate binding to rat brain synaptic membranes. It was suggested that 
CaZ+/Cl- expresses a new class of glutamate receptors. We report several ines of evidence suggesting that 
CaZ+/Cl- in fact favours a glutamate transport into membrane vesicles. This finding may serve to reconcile 
most of the discrepancies found in the literature on the glutamate binding and its pharmacology. 
Glutamate binding Ca2+/Cl- effect on glutamate receptor/transport 
1. INTRODUCTION 
L-Glutamate is thought to function as the major 
excitatory transmitter in the mammalian central 
nervous system [ 1,2]. Electrophysiological ex- 
periments have revealed that the actions of glutam- 
ate are mediated by multiple receptors, classically 
termed N-methyl-D-aspartate (NMDA), kainate 
(KA) and quisqualate (QA), according to their 
agonist specificities [3]. 
reconcile the discrepancies between [‘H]GLU bin- 
ding data performed under various experimental 
conditions. A preliminary account of this work has 
appeared as an abstract [lo]. 
2. MATERIALS AND METHODS 
Recent biochemical studies have shown that 
Ca2+/CI- increases the L-[3H]glutamate ([3H] 
GLU) binding by expressing a new class of recep- 
tors [4,5]. This Ca2+/C1--sensitive population of 
GLU binding sites is potently inhibited by L-2- 
amino-4-phosphonobutyrate (L-APB) [4] and DL- 
[3H]APB may label these sites [6]. Two hypotheses 
were proposed to explain this Ca’+/Cl- effect: (1) 
the linkage of some GLU sites to a membrane Cl- 
ion channel (4,7) analogous to the GABA system 
[8], or (2) the existence of a desensitised form of 
receptor [5] with divalent cations promoting the 
transition from a low affinity to a high affinity 
state (possible analogy with the nicotinic receptor 
[91). 
We report here that Ca2+/Cl- enhanced [3H] 
GLU binding seems to correspond to ligand ac- 
cumulation into membrane vesicles and not to 
receptor occupancy. These data may also serve to 
Whole brains from male Wistar rats were ho- 
mogenised in 20 vol. of ice-cold sucrose (0.32 M) 
and the homogenate centrifuged at 1000 x g for 10 
min at 4°C. The supernatant was recentrifuged 
(17 000 x g, 20 min) and the resultant pellet (Pz) 
lysed in 40 vol. of ice-cold distilled water (45 min). 
The membranes were centrifuged at 20 000 x g for 
35 min, then washed three times by resuspension in 
40 vol. of ice-cold water. The final pellet was 
resuspended in 50 mM Tris-citrate buffer, pH 7.4, 
and was diluted twice in the same buffer contain- 
ing or not Ca2+/CI- or another salt. Binding of 
[‘H]GLU was measured by incubating 100 ~1 ali- 
quots of membrane suspension, 100/11 of [3H]GLU 
(final concentration 100 nM) with 10 ~1 of buffer 
either free of added substances or containing 
unlabelled displacing substances at 1 mM. The 
final protein concentration ranged from 0.8 to 1 .O 
mg/ml. When Ca2+/Cl- or other salts were added, 
their final concentrations were 2.5 mM. Unless 
otherwise stated, the incubation was stopped after 
10 or 50 min, for binding experiments performed 
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at 37 or 0°C respectively, by adding 3.5 ml of 50 
mM ice-cold Tris-citrate buffer pH 7.4 and filtra- 
tion on Whatman glass filter (1 ,uM pore size). 
Filters were washed once with 3.5 ml of cold buffer 
and counted in a Kontron scintillation counter. 
Specific binding of [3H]GLU was determined by 
subtracting the non specific component (binding in 
the presence of 1 mM unlabelled GLU) from the 
total binding. 
Protein was assayed as described by Lowry et al. 
t111. 
3. RESULTS AND DISCUSSION 
The time course of Ca”/Cl--dependent [3H] 
GLU binding was biphasic at 37°C yet monophasic 
at 0°C (fig. 1). At 37°C the equilibrium value was 
reached at 8 min and was maintained for a further 
3-5 min, after which, the [3H]GLU binding 
decreased exponentially. This pattern is quite 
similar to that reported for the time-course of 
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Fig. 1. Time course of [3H]GLU binding to whole rat 
brain synaptic membranes at 0 or 37°C in absence or in 
presence of 2.5 mM Ca*+/Cl-. l , O”C, in absence of 
Ca2+/C1-; 0, O”C, 2.5 mM Ca’+/Cl-; A , 37”C, in 
absence of Ca2+/Cl-; A, 37”C, 2.5 mM Ca’+/Cl-. 
Membranes were prepared and specific binding of 
[3H]GLU (100 nM) measured as described in Materials 
and Methods. Results are means + SD from six separate 
experiments, each in duplicate and are expressed in 
pmol/mg protein. For clarity, the error bars have only 
been indicated in the figure for those experiments per- 
formed at 37°C. At O°C the SEM of each point differed 
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Fig. 2. Effect of external osmolarity on the [3H]GLU 
binding to rat whole brain membranes. Binding ex- 
periments were performed at 37°C as indicated in 
Materials and Methods. The osmolarity of the incuba- 
tion medium was increased by augmenting the sucrose 
concentration. Each point is a mean + SD of three 
separate experiments, each in duplicate. A , [3H]GLU 
binding (pmol/mg protein) at 37’C in absence of 
Ca2+/Cl-; A , [3H]CiLU binding (pmol/mg protein) at 
by less than 10%. 37°C in presence of Ca’+/Cl-. 
glutamate, aspartate and GABA transport into 
membrane vesicles prepared from rat brain 
[12,13]. In fact, the decay of the amount of 
radioactive compound taken up presumably results 
from the dissipation of the artificially imposed ion 
gradient [14] by a background ion flux [12] and not 
from receptor degradation by proteases. Proteases 
inhibitors did not inhibit this decay (data not 
shown). At O”C, the time-course of [3H]GLU bin- 
ding follows a classical Michaelis pattern (no decay 
after reaching the plateau). 
The second point to be emphasised from these 
experiments was that Ca’+/Cl- increased the 
[3H]GLU binding at 37”C, as previously reported 
[4], while Ca’+/Cl- slightly inhibited the [3H]GLU 
binding at 0°C [15]. 
It is known that low temperatures (0-4°C) 
dramatically reduce or render transport processes 
across membranes undetectable, whereas low 
temperatures only modify the kinetic constant of 
the binding, but not the binding process itself. 
Therefore, our results suggest the presence of GLU 
transport into the membrane vesicles rather than 
ligand binding to membranes, as aspartate and 
glutamate can bind at 0°C as well as 37°C [14-171. 
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Furthermore, at O”C, DL-f3H]APB, a potent 
agonist at the Ca’+fCl--sensitive GLU binding 
sites [6], does not bind to membranes even in the 
presence of Ca’+/Cl- 161. 
In order to distinguish uptake from binding, the 
osmolarity of the incubation medium was aug- 
mented by the addition of increasing concentra- 
tions of sucrose. The increasing osmolarity reduc- 
ed the intravesicular space of membrane vesicles. 
Thus, while uptake capacity decreases, ligand bin- 
ding to receptor sites remains unaffected. At 37”C, 
the effect of Ca2+/Cl- on the 13H]GLU binding 
depended on the osmolarity of the binding assay 
buffer (fig. 2), while the extent of binding in 
absence of Ca’+/Cl- was insensitive to the med- 
ium osmolarity (fig. 2). This provides additional 
evidence that the [3H]GLU binding in the presence 
of CaZf/Cl- does in fact correspond to transport 
of GLU into the membrane vesicles, as opposed to 
binding to the membrane. 
To further support our hypothesis on the ex- 
1 250 
Fig. 3. Effects of various cations on [3H]GLU binding to 
rat whole brain membranes. Binding in control samples 
was 2.22 4 0.30 pmoI/mg protein and taken as 100%. 
Binding experiments were performed at 37’C as describ- 
ed in Materials and Methods. Results are mean values 4 
SD of the percentage of binding as compared tocontrol 
samples (100%). Number in parentheses refers to the 
number of separate experiments. 
istence of a GLU transport mechanism, we ex- 
amined the ion specificity (fig. 3). Fig. 3 shows that 
in addition to Ca2+, several other divalent (Mg2’, 
Mn’+) and monovalent (Kf, Li+) cations as their 
chloride salt and at a concentration of 2.5 mM, in- 
crease the [3H]GLU binding when experiments are 
performed at 37’C in 50 mM Tris-citrate buffer, 
pH 7.4. These results suggest that there is no cation 
specificity. Moreover, this agrees with the fact that 
Mg2f/Cl- and Mn’+/Cl- were able to partially 
mimic the effects of Ca2+ on the DL-[3H]APB 
binding as previously reported [6]. 
Several anions, such as bromide, iodide, nitrate 
and sulfocyanate promoted the enhancement of 
13H)GLLJ binding, as did chloride. They were all 
permeant through membrane vesicles, synap- 
tosomes and cell membranes [14,19J. Impermeant 
anions, such as sulfate, gluconate and acetate were 
ineffective, whatever the cation considered. It is 
known that there is a high correlation between the 
degree of anion permeability, which creates a 
membrane potential (interior negative) and the 
enhancement of the initial rate of GLU transport 
into membrane vesicles. We observed that the 
anion order of potency which enhanced [3H]GLU 
binding {fig. 3) is similar to that reported for in- 
creasing the glut~ate/aspa~ate rate of uptake in- 
to membrane vesicles (20,211. These results in- 
dicated an anion specificity permeant anions being 
effective in i creasing [3H]GLU binding, imper- 
meant anions P being inefficient. They revealed that 
Ca2+ is the most effective counter ion. This further 
strengthens the possibility of an electrogenic GLU 
transport into membrane vesicles. It may be sug- 
gested that the membrane potential (interior 
negative) is created by the differential permeability 
of the anion (e.g. Cl-) with respect to the cation 
(e.g. Ca’+) through the membranes of the vesicles. 
This implied that GLU, which presents a net 
charge of - 1 at pH 7.4, is transported with a 
divalent cation or two monovalent cations in a 
complex possessing a net charge of -I- 1. 
The Ca2+/Cl- enhanced [3H]GLU binding 
previously observed, was reported to be due to an 
increase in the number of binding sites, with no 
change in their affinity [4]. Incidentally, we found 
that the density of these sites was about 85 pmol/ 
mg protein, which appears to closely correlate to 
the capacity of a transport mechanism, rather than 
to a maximal number of binding sites. 
33 
Volume 175, number 1 FEBS LETTERS September 1984 
Electron micrograph (fig. 4) of the membrane 
preparation, used in our binding experiments, 
revealed the presence of several membrane vesi- 
cles, despite the multiple h~otonic shock (45 min 
in distihed ice-cold water followed by three main 
washings). Our membrane preparation was derived 
from that previously described [28) and commonly 
used for binding assays. 
All our data suggested that the Ca’+/Cl- effect 
on the GLU binding was due to a GLU transport 
mechanism. However, L-GLU, L-aspartate and 
GABA are known to be sequestered in nerve ter- 
minal preparations (synaptosomes) [19,22,23], 
brain slices 1241 and membrane vesicles 1201. A 
high affinity Nat-dependent uptake system shared 
by acidic amino acid (GLU, aspartate) has been 
described [13,19,24], The active transport of these 
compounds occurred with a net charge of +2 
[ 13,261. The problem of the transport mechanism 
specificity, revealed in the presence of Ca2’/CI-, 
as compared to the classical high affinity GLU up- 
take, was raised. Thus, we examined the phar- 
macology of these phenomena. Although D-ASP, 
which is a poor displacing agent of the [3H]GLU 
binding determined in the absence of Ca2+/C1- 
and a relatively potent inhibitor of GLU uptake, 
displaced the Ca2+/Cl- dependent GLU binding 
effectively, D-GLU and quisqualate, both weak 
Fig. 4. Electron micrograph of the rat brain membrane at a magnification of 12000 showing the presence of membrane 
vesicles in the preparation used for binding assays. The membrane preparation was performed as reported in Materials 
and Methods. After resuspension in 50 mM Tris-citrate buffer, pH 7.4, the membranes were centrifuged at 50 000 x g 
for 30 min. The resulting pellet was fixed with the Tris-citrate buffer containing 5% glutaraldehyde and post-fixed with 
1% osmium tetroxyde in 0.2 M cacodylate buffer. After graduated ehydration with alcohol, the samples were embed- 
ded in spur resing. Ultrathin sections (70 nm) stained with uranyl acetate and lead citrate were examined with a 100 
B Jeol electron microscope. Arrows indicate membrane vesicles. 
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GLU uptake inhibitors, displaced the Ca2+/ 
Cl--dependent GLU binding with high affinity 
(data not shown, [4,5]). Moreover, DL-APB (1 
mM) inhibited only 3Oqo of the [‘H]GLU uptake 
into synaptosomes at appropriate protein concen- 
trations (0.02-0.2 mg/ ml), for a 10 min incuba- 
tion period (data not shown) in agreement with in- 
hibition by APB of the GLU uptake in rat striatum 
[27]. We found that DL-APB displaced up to 80% 
of the Ca”/Cl--dependent GLU binding, as 
previously reported [4,5]. It is clear, that the up- 
take mechanism, described in this paper, did not 
correspond to the classical high affinity uptake, in 
fact, it occurred in: 
(1) a hypotonic medium (50 mM Tris-citrate) 
and not in a isoosmotic medium; 
(2) the presence of only 2.5 mM Ca2+/Cl- and 
not in the presence of imposed Nd> Na: and 
KZ > KZ gradients like in membrane vesicles, or in 
presence of a gradient created by the ATPase like 
in synaptosomes; 
(3) a membrane preparation (1 mg/ml protein) 
containing few vesicles, with a different membrane 
permeability due to the hypotonic medium and low 
temperature. 
Finally, we suggest that Ca2+/C1--enhanced 
[3H]GLU binding does in fact correspond to 
transport of a complex GLU--Ca2+ into mem- 
brane vesicles in a hypotonic medium, the driving 
force being generated by the relative permeability 
of the anion (Cl-) in relation to that of the cation 
(Ca2+). 
4. GENERAL DISCUSSION AND 
CONCLUSION 
Our data strongly suggest that Ca’+/Cl- 
-enhanced [3H]GLU binding does in fact corres- 
pond to transport of GLU into membrane vesicles, 
as supported by the following points: 
(1) the time course of Ca’+/Cl--dependent 
[3H]GLU binding followed the pattern of uptake 
of excitatory amino acids into synaptic vesicles; 
(2) low temperatures (0-4°C) completely abolish 
the Ca’+/Cl- effects; 
(3) increasing the osmolarity of the incubation 
medium, decreases the Ca’+/Cl- enhancement of 
L-[3H]GLU binding, without affecting the GLU 
binding itself; 
(4) the cation and anion specificity coincide with 
the ability of these ions to create membrane poten- 
tial, permeant anions being efficient (Cl-, Br-, 
SCN-, NOs), impermeant anions (SO:-, 
gluconate, acetate) being ineffective. 
(5) the density of ‘binding sites’ (80-100 pmol/ 
mg protein) fit better with an uptake capacity than 
with a number of receptor sites; the & is in the 
pmolar range; 
(6) electron micrograph revealed the presence of 
membrane vesicles in extensively water-washed 
membranes. 
These data may also serve to reconcile the 
discrepancies between GLU binding data [3,5,16, 
17,281 at 0 and 37°C since the latter may contain 
a significant uptake component depending on the 
nature of the buffer used. They could explain 
several effects such as sonication, freezing, thaw- 
ing, effects of triton on ‘glutamate binding’ per- 
formed in buffer containing Cl- ions. It was 
reported that sonication increased glutamate bin- 
ding up to 33 fold and it is known that sonication 
favours the vesiculation of membranes. Freezing 
and thawing, which breaks membrane vesicles, in- 
hibited ‘glutamate binding’ by 90% [29-311. When 
membranes are thawed rapidly at 38”C, (maintain- 
ing the integrity of membrane vesicles and the up- 
take capacity) only a slight decrease in glutamate 
binding was observed. It seems difficult to assess 
the physiological significance of the Ca’+/Cl- 
-enhanced t3H]GLU binding. APB, the most 
potent inhibitor of this binding, was reported to be 
synaptic depressant [32,33], although weak ex- 
citatory effects of APB have also been observed 
[34-361. It has also been suggested that the 
distribution of these sites, determined by 
autoradiography in hippocampal slices, cor- 
responds to the terminal fields of proposed 
glutamatergic pathways [37]. To explain these 
physiological effects of APB, it might be suggested 
that the transport phenomenon of the 
glutamate-calcium complex, different from the 
classical Na+-dependent glutamate uptake, cor- 
responds to one of the mechanisms which allow the 
Ca2+ entrance into he cells, leading, for example, 
to the well-known cell toxicity of glutamate, as 
recently reported [38]. This possibility is now being 
investigated. 
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